Diabetes Mellitus, Type 2: all 9,590 studies
Page 62 of 96. Open to participants first (1,331), then studies with results posted, then the rest; newest registration first within each.
- Compliance to HIT-program at Home With the Use of TechnologyCompletedNCT03166852Not applicable
- Effect of Low-glycemic Index Meals Intake on DM2 Women Under Metformin TherapyCompletedNCT03165877Not applicable
- A Diabetes Improvement in Medical Therapy Versus SADJB StudyStatus unknownNCT03165812Not applicable
- Person-centred Interactive Self-management Support in Primary Healthcare for People With Type 2 DiabetesStatus unknownNCT03165084Not applicable
- Efficacy and Safety of Jinshuibao Capsule on Diabetic Kidney DiseaseCompletedNCT03164785Phase 2/3
- Evaluation of Type 2 Diabetes TreatmentCompletedNCT03164187
- Efficacy of an Electronic System to Support Clinical Decisions in Adults With Type 2 Diabetes Mellitus.Status unknownNCT03160196Not applicable
- Safety and Pharmacokinetics/Pharmacodynamics of SHR3824 in Type 2 Diabetes Patients With Renal InsufficientStatus unknownNCT03159832Phase 1
- Behavioral Family Systems Therapy (BFST) for Teens With Type 2 DiabetesCompletedNCT03159221Not applicable
- Efficacy and Safety of SHR3824 as Monotherapy in Subjects With Type 2 DiabetesStatus unknownNCT03159052Phase 3
- Effect of Acute Fructose Load in HumanCompletedNCT03157960Not applicable
- Multi-center, Single Arm, Observational Study to Evaluate the Safety of Dapagliflozin in Type 2 Diabetes Mellitus Patients in ChinaCompletedNCT03156985
- Glycemic Response to Six Meal Replacements in Persons With Type 2 Diabetes MellitusCompletedNCT03155867Not applicable
- Adipose Tissue Expandability and Type 2 DiabetesCompletedNCT03155412
- PRKAA2 Genetic Polymorphisms and Its Susceptibility to Chinese Type 2 Diabetes Mellitus and Diabetic NephropathyCompletedNCT03155087
- The Early Predictors for Developing Type 2 Diabetes Mellitus in Patients With Chronic Obstructive Pulmonary DiseaseCompletedNCT03152994
- Hypoglycemic Efficacy of Greenyn Momordica Charantia Extracts in Diabetic SubjectsCompletedNCT03151837Not applicable
- Hypoglycaemia and Cardiac Arrhythmias in Type 2 DiabetesCompletedNCT03150030
- Comparing Moderate and High-intensity Interval Training Protocols on Biomarkers in Type 2 Diabetes PatientsCompletedNCT03144505Not applicable
- Dose Escalation Trial of Single Subcutaneous Doses of NNC 0113-0217 to Assess Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Healthy Male SubjectsCompletedNCT03144271Phase 1
- Cardiorespiratory Fitness Using Electrically Assisted BicyclesCompletedNCT03143764Not applicable
- Commercial Prebiotic Supplement StudyCompletedNCT03141710Not applicable
- Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM SubjectsCompletedNCT03141073Phase 3
- Insulin Sensitivity During Hyperbaric Oxygen Compared to Hyperbaric AirCompletedNCT03138746
- A Digital Health Tool for Insulin Titration (DHIT) Individuals With Type 2 Diabetes: A Prospective Outcomes Study With a Retrospective Control GroupCompletedNCT03138447Not applicable
- Bioequivalence Study of Combination Tablets of Saxagliptin / Dapagliflozin / Metformin XR (Extended-release) and Dapagliflozin / Metformin XR Relative to Individual Components in Healthy SubjectsCompletedNCT03138356Phase 1
- Impact of CMS Reimbursement Policy Supporting Care Coordination in LouisianaCompletedNCT03136471
- Effect of Pharmacists Treating Diabetes in a FQHCStatus unknownNCT03134170Not applicable
- Empagliflozin as a Modulator of Systemic Vascular Resistance and Cardiac Output in Patients With Type 2 DiabetesCompletedNCT03132181Phase 2
- The Effect of Empagliflozin on Glucose Metabolism, Weight, Blood Pressure and Cardiac Function (NT-proBNP) Should be InvestigatedStatus unknownNCT03131232
- Association Between TMAO and DiabetesCompletedNCT03130894
- Remission Evaluation of a Metabolic Intervention for Type 2 Diabetes With IGlarLixiCompletedNCT03130426Phase 3
- Procedure for Duodenum to Ileal Diversion to Treat Type 2 DiabetesActive, not recruitingNCT03130244Not applicable
- Randomised Placebo-controlled Study of FMT to Impact Body Weight and Glycemic Control in Obese Subjects With T2DMCompletedNCT03127696Not applicable
- Sitagliptin vs. Pioglitazone as add-on Treatments in Patients With Type 2 Diabetes Uncontrolled on the Full-dose Metformin Plus SulfonylureaCompletedNCT03125694Phase 3
- Get In Touch Phase 2CompletedNCT03124043Not applicable
- CCK1R Function in Patient LeukocytesCompletedNCT03121755
- Taking on Diabetes to Advance You (TODAY)WithdrawnNCT03121508Not applicable
- Microbiome Insulin Sensitivity StudyCompletedNCT03120871
- The Effect of Omega-3 FA on Hypertriglyceridemia in Patients With T2DM(OCEAN)CompletedNCT03120299Phase 4
- A Study to Evaluate the Renal Protective Effect (Urine Albumin-to-Creatinine Ratio (UACR)), Efficacy and Safety of Ipragliflozin in Type 2 Diabetes Mellitus Patients With AlbuminuriaTerminatedNCT03118713Phase 4
- A Study of LY3325656 in Healthy Participants and Participants With Type 2 DiabetesCompletedNCT03115099Phase 1
- Improving Glycaemic Control in Malaysian Patients With Type 2 Diabetes Mellitus With Insulin Pump TherapyStatus unknownNCT03112538Phase 4
- Effect of SLC30A8 rs13266634 Genetic Polymorphism on Zinc Supplementation and Glycemic Control in Egyptian Patients With Type 2 Diabetes MellitusCompletedNCT03112382Phase 4
- The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and DMTerminatedNCT03111238Phase 3
- Novel Strategies to Improve Cardiometabolic Status and Adherence to Exercise Regimens in Patients at High Risk for Cardiovascular DiseaseStatus unknownNCT03103854Not applicable
- HOme-Based Exercise for Patients With Type 2 DiabetesWithdrawnNCT03103126Not applicable
- A Study to Identify Biomarkers of Hypoglycaemia in Patients With Type 2 DiabetesCompletedNCT03102801Not applicable
- Transcutaneous Electrical Nerve Stimulator to Improve Blood Glucose Control in Patients With Type 2 Diabetes MellitusCompletedNCT03102424Not applicable
- Developing a Positive Psychology Intervention to Improve Health Behaviors in Type 2 Diabetes: Qualitative ResearchCompletedNCT03099928
- Impact of Integrated HIV/NCD Screening on HIV Testing Uptake and Engagement in HIV Care in Kisarawe, TanzaniaCompletedNCT03098654Not applicable
- Cardiorespiratory Parameters and Glycated Hemoglobin of Patients With Type 2 Diabetes After a Rehabilitation ProgramStatus unknownNCT03094767Not applicable
- Digital Self-Management Program for Medicare Advantage Members With Type 2 Diabetes- Impact on A1cCompletedNCT03092882Not applicable
- Using Multifamily Groups to Improve Self-Management of Type 2 DiabetesCompletedNCT03092063Not applicable
- Insulin Degludec Titration Using Mobile Insulin Dosing SystemCompletedNCT03091712Not applicable
- A Single Arm Feasibility Study of GlycoLeap, an On-line Lifestyle Modification and Self-management Program for People With Type 2 DiabetesCompletedNCT03091517Not applicable
- A 6-month Clinical Study to Evaluate the Effect of a Digital Disease Management Tool in Patients With T2DMCompletedNCT03090464
- Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive SubjectsCompletedNCT03089333Phase 4
- Efficacy and Safety of Gosogliptin as Monotherapy and in Combination With Metformin vs. Vildagliptin as Monotherapy and in Combination With Metformin in Drug-naive Type 2 Diabetic Patients.CompletedNCT03088670Phase 3
- Retrospective Study of Patients With Type 2 Diabetes Mellitus on Dapagliflozin Therapy in TaiwanCompletedNCT03084965
- The Effect of Social Relationships on Psychological Distress and Disease Progression in Patients With DiabetesStatus unknownNCT03083795Not applicable
- Acute Exercise and Free-living Glycaemic Control in Type 2 DiabetesStatus unknownNCT03082859Not applicable
- The Effect of GIP and GLP-1 on Insulin and Glucagon Secretion in Patients With HNF1A-diabetes Treated With or Without SulphonylureaCompletedNCT03081676Not applicable
- Study to Evaluate Safety, Efficacy of PBI-4050 & Its Effect on Relevant Biomarkers in T2DM Patients With Metabolic SyndromeTerminatedNCT03081598Phase 2
- The Adaptation, Usability, and Feasibility of a Mobile Health (mHealth) System to Improve Type 2 Diabetes Self-management in ThailandCompletedNCT03078764Not applicable
- EMPRA (EMPagliflozin and RAs in Kidney Disease)CompletedNCT03078101Phase 2
- Characteristics of Patients With Type 2 Diabetes Mellitus Receiving Treatment With Dapagliflozin Versus Sitagliptin: An Analysis of Commercial Claims and Linked Laboratory DataCompletedNCT03078049
- Enhancing Community Health Through Patient Navigation, Advocacy and Social SupportCompletedNCT03077386Not applicable
- Efficacy of Ipragliflozin Compared With Sitagliptin in Uncontrolled Type 2 Diabetes With Sulfonylurea and MetforminCompletedNCT03076112Phase 3
- Improvement of Care for Outpatients With Type 2 Diabetes Through Self-Care Multidisciplinary Workshop for DiabetesCompletedNCT03074383Not applicable
- Registry Observing EndoBarrier® Treatment Outcomes in Subjects With Type 2 Diabetes and/or ObesityTerminatedNCT03072901
- MAD Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PB-119 to Subjects With T2DMCompletedNCT03072407Phase 1
- QUANtification of Cardiovascular Autonomic Neuropathy (CAN) and the Effects of Anaesthesia on Haemodynamics and Cerebral PerfusionCompletedNCT03071432Not applicable
- Usage of Dapagliflozin in the Management of Type-2 Diabetes Mellitus: A Real World Evidence Study in Indian PatientsCompletedNCT03071016
- Non-interventional, Post Marketing Surveillance Study of Xultophy™ (Insulin Degludec/Liraglutide) to Evaluate Long Term Safety and Efficacy in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in IndiaWithdrawnNCT03070704
- Diabetes: Functional Medicine Approach Vs. Usual CareCompletedNCT03070106Not applicable
- A Reduced-carbohydrate Diet High in Monounsaturated Fats in Type 2 DiabetesCompletedNCT03068078Not applicable
- Antidiabetic Effects on Intrahepatic FatCompletedNCT03068065Phase 4
- Clinical Evaluation of Fenfuro (Fenugreek Seed Extract) in Type-2 Diabetic Subjects: an add-on StudyCompletedNCT03066089Phase 4
- Targeted Enteral Nutrient Delivery: A Prospective Randomized StudyCompletedNCT03064347Not applicable
- Diabetes Sleep Treatment Trial for InsomniaCompletedNCT03064321Not applicable
- Continuous Multiple Dose PB-119 Injection in Health VolunteersCompletedNCT03062774Phase 1
- FFAR Agonist on Incretins, Insulin, Lipids and InflammationCompletedNCT03062592Not applicable
- A Study To Evaluate The Safety,Tolerability, PK and PD Of DA-1241 In Healthy Male SubjectsCompletedNCT03061981Phase 1
- The Individualized Behavioral Intervention of Smartphone App in the Treatment of Type 2 Diabetes MellitusStatus unknownNCT03061851Not applicable
- The Application of the E-health Education on Shared Care Program for Patients With Type 2 DiabetesStatus unknownNCT03061266Not applicable
- Comparison of Efficacy, Safety, and Tolerability of ITCA 650 to Empagliflozin and Glimepiride as add-on MetforminTerminatedNCT03060980Phase 3
- A Multiple Ascending Dose Study to Evaluate Safety and Tolerability of BFKB8488A in Participants With Type 2 Diabetes Mellitus and Participants With Non-Alcoholic Fatty Liver DiseaseCompletedNCT03060538Phase 1
- Clinical Trial for PB-119 in Subjects With Type 2 Diabetes MellitusCompletedNCT03059719Phase 1
- Resistant Starch, Gut Bacteria and DiabetesCompletedNCT03057444Not applicable
- Using Mobile Phone Short Message Service (SMS) Reminders to Enhance Appointment Attendance in DM PatientsStatus unknownNCT03055702Not applicable
- App-technology to Increase Physical Activity Among Patients With Type 2 DiabetesCompletedNCT03053336Not applicable
- SGLT-2i and ARB Combination Therapy in Patients With T2DM and Nocturnal Hypertension (SACRA Study)CompletedNCT03050229Phase 4
- In and ex Vivo Mitochondrial Function of the HeartCompletedNCT03049228
- POLY-unsaturated Fatty Acids in the Preservation of Dietary Effects on Hepatosteatosis and Energy Metabolism in Type 2 DiabetesStatus unknownNCT03047668Not applicable
- Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain.CompletedNCT03047278Phase 4
- Anatomical and Physiological Characterisation of the Gut Endocrine Cells in Healthy and in Patients With Type 2 DiabetesCompletedNCT03044860Not applicable
- Safety and Efficacy of Alogliptin in Indian Participants With Type 2 Diabetes MellitusWithdrawnNCT03042325Phase 4
- XIGDUO Extended Release (XR) Post Marketing SurveillanceCompletedNCT03038789
- Elucidating the Mechanism of Remission of Type 2 Diabetes in Morbid Obese Patients After Bariatric SurgeryStatus unknownNCT03038373